236 related articles for article (PubMed ID: 684075)
21. The behavioral effects of hallucinogens in rats following 5,7-dihydroxytryptamine administration into the medial forebrain bundle.
Commissaris RL; Mokler DJ; Lyness WH; Moore KE; Rech RH
Pharmacol Biochem Behav; 1981 Jun; 14(6):915-8. PubMed ID: 6973157
[TBL] [Abstract][Full Text] [Related]
22. [Effects of intraventricular injection of 5,7-dihydroxytryptamine on monoamines and sleep in the kitten (author's transl)].
Adrien J; Bourgoin S; Laguzzi R; Hamon M
J Physiol (Paris); 1981; 77(2-3):425-30. PubMed ID: 7288656
[TBL] [Abstract][Full Text] [Related]
23. Developmental changes in serotonin and 5-hydroxyindoleacetic acid concentrations and opiate receptor binding in rat spinal cord following neonatal 5,7-dihydroxytryptamine treatment.
Kirby ML; Mattio TG
Dev Neurosci; 1982; 5(5-6):394-402. PubMed ID: 6186451
[TBL] [Abstract][Full Text] [Related]
24. The effect of 5,7-dihydroxytryptamine on the serum corticosterone resistance to suppression by dexamethasone.
McIntyre IM; Oxenkrug GF; Stanley M; Gershon S
Brain Res; 1984 Aug; 309(1):156-8. PubMed ID: 6488005
[TBL] [Abstract][Full Text] [Related]
25. Intrahypothalamic 5,7-dihydroxytryptamine: temporal analysis of effects on 5-hydroxytryptamine content in brain nuclei and on facilitated lordosis behavior.
Frankfurt M; Renner K; Azmitia E; Luine V
Brain Res; 1985 Aug; 340(1):127-33. PubMed ID: 4027638
[TBL] [Abstract][Full Text] [Related]
26. Hippocampal cell nuclear binding of corticosterone following 5,7-dihydroxytryptamine.
Siegel RA; Weidenfeld J; Chen M; Feldman S; Melamed E; Chowers I
Mol Cell Endocrinol; 1983 Aug; 31(2-3):253-9. PubMed ID: 6195032
[TBL] [Abstract][Full Text] [Related]
27. 6-Hydroxydopamine and 5,7-dihydroxytryptamine selectively reduce dopamine and 5-hydroxytryptamine metabolites in cerebroventricular perfusates of rats.
Nielsen JA; Moore KE
Pharmacol Biochem Behav; 1983 Nov; 19(5):905-7. PubMed ID: 6417682
[TBL] [Abstract][Full Text] [Related]
28. 5,7-Dihydroxytryptamine lesions of the ascending 5-hydroxytryptamine pathways: habituation, motor activity and agonistic behavior.
Hole K; Johnson GE; Berge OG
Pharmacol Biochem Behav; 1977 Sep; 7(3):205-10. PubMed ID: 563078
[TBL] [Abstract][Full Text] [Related]
29. The ability of local injection of 6-OHDA, 5,6-DHT and 5,7-DHT into the olfactory bulbs to mimic the effects of bilateral bulbectomy in the rat [proceedings].
Cairncross KD; Cox B; Forster C; Wren A
Br J Pharmacol; 1977 Sep; 61(1):145P-146P. PubMed ID: 912193
[No Abstract] [Full Text] [Related]
30. Effects of neonatal treatment with 5,7-dihydroxytryptamine or 6-hydroxydopamine on the ontogenetic development of the audiogenic immobility reaction in the rat.
Hard E; Ahlenius S; Engel J
Psychopharmacology (Berl); 1983; 80(3):269-74. PubMed ID: 6412273
[TBL] [Abstract][Full Text] [Related]
31. Rotational responses to serotonergic and dopaminergic agonists after unilateral dihydroxytryptamine lesions of the medial forebrain bundle: co-operative interactions of serotonin and dopamine in neostriatum.
Waddington JL; Crow TJ
Life Sci; 1979 Oct; 25(15):1307-14. PubMed ID: 316093
[No Abstract] [Full Text] [Related]
32. Evaluation of the cytotoxicity of dihydroxytryptamines and 5-hydroxytryptamine antagonists as cytotoxic agents in dimethylhydrazine-induced adenocarcinomata.
Tutton PJ; Barkla DH
Cancer Chemother Pharmacol; 1978; 1(4):209-13. PubMed ID: 35286
[TBL] [Abstract][Full Text] [Related]
33. Alcohol intake, ethanol-induced narcosis and intoxication in rats following neonatal 6-hydroxydopamine or 5, 7-dihydroxytryptamine treatment.
Kiianmaa K; Attila LM
Naunyn Schmiedebergs Arch Pharmacol; 1979 Aug; 308(2):165-70. PubMed ID: 574195
[TBL] [Abstract][Full Text] [Related]
34. Effect of 5,7-dihydroxytryptamine on serotonergic control of prolactin secretion and behavior in rats.
Kuhn CM; Vogel RA; Mailman RB; Mueller RA; Schanberg SM; Breese GR
Psychopharmacology (Berl); 1981; 73(2):188-93. PubMed ID: 6785814
[TBL] [Abstract][Full Text] [Related]
35. Similar motor effects of 5-HT and TRH in rats following chronic spinal transection and 5.7-dihydroxytryptamine injection.
Barbeau H; Bédard P
Neuropharmacology; 1981 May; 20(5):477-81. PubMed ID: 6165921
[No Abstract] [Full Text] [Related]
36. Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat.
Nelson DL; Herbet A; Bourgoin S; Glowinski J; Hamon M
Mol Pharmacol; 1978 Nov; 14(6):983-95. PubMed ID: 732817
[No Abstract] [Full Text] [Related]
37. Involvement of noradrenergic and 5-hydroxytryptaminergic systems in allylnitrile-induced head twitching.
Tanii H; Huang J; Hashimoto K
Brain Res; 1993 Oct; 626(1-2):265-71. PubMed ID: 7506631
[TBL] [Abstract][Full Text] [Related]
38. Serotonin turnover and supersensitivity after neonatal 5,7-dihydroxytryptamine.
Mueller RA; Towle A; Breese GR
Pharmacol Biochem Behav; 1985 Feb; 22(2):221-5. PubMed ID: 2580321
[TBL] [Abstract][Full Text] [Related]
39. Brainstem serotonergic hyperinnervation modifies behavioral supersensitivity to 5-hydroxytryptophan in the rat.
Pranzatelli MR; Huang YY; Dollison AM; Stanley M
Brain Res Dev Brain Res; 1989 Nov; 50(1):89-99. PubMed ID: 2582610
[TBL] [Abstract][Full Text] [Related]
40. Comparison of the behavioral and neurochemical effects of 5,7-DHT, MDMA and D,L-fenfluramine.
Lorens SA; Hata N; Cabrera T; Hamilton ME
NIDA Res Monogr; 1989; 95():347. PubMed ID: 2577039
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
